Cochrane · systematic review · CD001798

Plasma exchange for Guillain‐Barré syndrome

Chevret, S, Hughes, RAC, Annane, D · Cochrane Database of Systematic Reviews · 2017 · Cochrane Library

Neuromuscular2 versionsAMSTAR 2: not assessed
SoF tableOnly the outcomes this review put in its Summary of Findings table are listed (the Cochrane Handbook caps them at about seven per comparison). Its other analyses are not shown here.
Questions
7
current version
GRADE rated
6
No studies
0
Included studies
NR
No studies 0 · 0%Ungraded 1 · 14.3%Very low 0 · 0%Low 0 · 0%Moderate 5 · 71.4%High 1 · 14.3%

Ungraded means an effect was reported without a GRADE rating; it is not a gap. No studies means the review found nothing to answer the question. The six categories are a display order, not a score.

Questions and results

Show all 2 versions

Plasma exchange compared to sham exchange or supportive treatment for Guillain‐Barré syndrome

Population: people with Guillain‐Barré syndrome
7 questions
OutcomeEffectEvidenceStatus / GRADE
Walking with aid at 4 weeks
Plasma exchange vs sham exchange or supportive treatment
RR 1.6 [1.19, 2.15]3 studies · 349 participantsModerate
Downgraded: risk of bias
Dependency on a ventilator at 4 weeks
Plasma exchange vs sham exchange or supportive treatment
RR 0.53 [0.39, 0.74]5 studies · 623 participantsModerate
Downgraded: risk of bias
Full muscle strength recovery at 1 year
Plasma exchange vs sham exchange or supportive treatment
RR 1.24 [1.07, 1.45]5 studies · 404 participantsModerate
Downgraded: risk of bias
Relapses at 1 year
Plasma exchange vs sham exchange or supportive treatment
RR 2.89 [1.05, 7.93]6 studies · 649 participantsModerate
Downgraded: risk of bias
Deaths at 1 year
Plasma exchange vs sham exchange or supportive treatment
RR 0.86 [0.45, 1.65]6 studies · 649 participantsHigh
Severe infection
Plasma exchange vs sham exchange or supportive treatment
RR 0.91 [0.73, 1.13]3 studies · 556 participantsModerate
Downgraded: risk of bias
1Trials were not blinded.
Plasma exchange vs sham exchange or supportive treatment
no estimate extracted1 participantsUngraded